Pascale André

Innate Pharma (France) — France

Immunology and Microbiology · Life Sciences

33h-index8.6kcitations112works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(84), T-cell and B-cell Immunology(35), Cancer Immunotherapy and Biomarkers(18), CAR-T cell therapy research(15), Immunotherapy and Immune Responses(11)

Publications112 total

PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade
Journal of Experimental & Clinical Cancer Research·2025· 2 citedOpen Access
1083 Preclinical characterization of IPH6501: a novel IL2v-armed tetraspecific NK cell engager targeting CD20 in relapsed or refractory B cell non-Hodgkin lymphoma subtypes and post-CAR-T therapy
Regular and Young Investigator Award Abstracts·2024Open Access
1003P A first-in-human (FIH) phase I study of IPH5301, an anti-CD73 monoclonal antibody (mAb), in patients with advanced solid tumors (AST) (CHANCES, NCT05143970)
Annals of Oncology·2024
Randomized Phase 2 Trial of Lirilumab as maintenance Treatment in Acute Myeloid Leukemia: Results of the EFFIKIR Trial
2024Open Access
1290TiP A phase II multicenter, open label, non-randomized study of neoadjuvant and adjuvant treatment with IPH5201 and durvalumab in patients with resectable, early-stage (II to IIIA) non-small cell lung cancer (MATISSE)
Annals of Oncology·2023· 2 citedOpen Access
Supplementary Figure 6 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Table 2 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Figures 1-5 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Figure 6 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Table 1 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Figure Legends 1-6 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Data from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Table 1 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Figures 1-5 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Data from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Figure Legends 1-6 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Supplementary Table 2 from Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2023Open Access
Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors
The Journal of Clinical Pharmacology·2023· 5 cited
123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
Annals of Oncology·2021· 12 citedOpen Access
CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer
Cancers·2021· 35 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Éric Vivier(25), François Romagné(12), Robert Zerbib(10), Yannis Morel(9), Mathieu Bléry(8), Cécile Bonnafous(7), Nicolas Fuséri(6), Nicolai Wagtmann(6), Sophie Guia(5), Ariane Morel(5), Alessandro Moretta(5), Norbert Vey(5), Nicolas Anfossi(4), Sophie Ugolini(4), Laurent Gauthier(4), Agnès Boyer-Chammard(4), Marie‐Laure Thibult(4), Daniel Olive(4), Fabien Chanuc(4), Don M. Benson(4)